Sr. Manager, Study Start Up

Role: Senior Manager, Study Start-up, oversees global clinical trial initiation and site activation for Phase I-III and real-world evidence studies at Alnylam. Objectives include driving efficient start-up processes, ensuring timely site activation, and optimizing milestone achievement. Responsibilities encompass developing global start-up plans, partnering with CROs, facilitating study planning, analyzing trial data for accurate forecasting, and implementing process improvements. The role requires managing cross-functional teams, external vendors, and stakeholders to accelerate study delivery while maintaining compliance with GCP and regulatory standards. Qualifications: Bachelor's in Science or related discipline; 8+ years of experience in clinical operations within CROs or biopharma, including substantial global start-up and site activation expertise; strong knowledge of GCP, study management, and local regulations. Preferred: higher degrees, extensive experience managing international clinical studies and CRO collaborations. HighValue: involvement in multinational Phase I-III or real-world evidence trials, expertise in study start-up, site activation, and operational excellence within biopharma. WorkSetup: not specified, but likely hybrid or remote based on global scope; travel requirements not detailed.